Back
Neumora Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Sell
26
NMRA
Neumora Therapeutics
Last Price:
10.33
Seasonality Move:
43.48%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NMRA is experiencing slight selling pressure.
Neumora Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.24 | Buy |
| 20-day SMA: | 10.01 | Buy |
| 50-day SMA: | 12.13 | Sell |
| 200-day SMA: | 11.78 | Sell |
| 8-day EMA: | 10.29 | Buy |
| 20-day EMA: | 10.45 | Sell |
| 50-day EMA: | 11.27 | Sell |
| 200-day EMA: | 12.17 | Sell |
Neumora Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 44.82 | Sell |
| Chaikin Money Flow: | -283451 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.38 - 11.52) | Sell |
| Bollinger Bands (100): | (10.4 - 13.74) | Sell |
Neumora Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neumora Therapeutics Stock
Is Neumora Therapeutics Stock a Buy?
- Neumora Therapeutics share price is 10.32 while NMRA 8-day simple moving average is 10.24, which is a Buy signal.
- The stock price of NMRA is 10.32 while Neumora Therapeutics 20-day SMA is 10.01, which makes it a Buy.
- Neumora Therapeutics 50-day simple moving average is 12.13 while NMRA share price is 10.32, making it a Sell technically.
- NMRA stock price is 10.32 and Neumora Therapeutics 200-day simple moving average is 11.78, creating a Sell signal.
NMRA Technical Analysis vs Fundamental Analysis
Sell
26
Neumora Therapeutics (NMRA)
is a Sell
Is Neumora Therapeutics a Buy or a Sell?
-
Neumora Therapeutics stock is rated a Sell
The current Neumora Therapeutics [NMRA] share price is $10.32. The Score for NMRA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Neumora Therapeutics Stock Info
Market Cap:
1.67B
Price in USD:
10.32
Share Volume:
859.23K
Neumora Therapeutics 52-Week Range
52-Week High:
21.00
52-Week Low:
8.33
Sell
26
Neumora Therapeutics (NMRA)
is a Sell
Neumora Therapeutics Share Price Forecast
-
What is the Neumora Therapeutics stock price today?
The Neumora Therapeutics stock price is 10.32 USD today. -
Will NMRA stock go up or go down?
Neumora Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Neumora Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neumora Therapeutics is overvalued.
Is Neumora Therapeutics Stock a Buy?
- Neumora Therapeutics share price is 10.32 while NMRA 8-day exponential moving average is 10.29, which is a Buy signal.
- The stock price of NMRA is 10.32 while Neumora Therapeutics 20-day EMA is 10.45, which makes it a Sell.
- Neumora Therapeutics 50-day exponential moving average is 11.27 while NMRA share price is 10.32, making it a Sell technically.
- NMRA stock price is 10.32 and Neumora Therapeutics 200-day simple moving average is 12.17, creating a Sell signal.
Fundamental Analysis of Neumora Therapeutics
Is Neumora Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Neumora Therapeutics
Should I short Neumora Therapeutics stock?
- NMRA Moving Average Covergence Divergence (MACD) indicator is -0.39, suggesting Neumora Therapeutics is a Sell
- Neumora Therapeutics Relative Strength Index (RSI) is 44.82, which suggest Neumora Therapeutics is oversold
- The Bollinger Bands (25) for Neumora Therapeutics is (9.38 - 11.52), which suggest Neumora Therapeutics is a Sell
- The Bollinger Bands (100) for Neumora Therapeutics is (10.4 - 13.74), which suggest Neumora Therapeutics is a Sell
* Neumora Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.